CorePharma Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Debt - PPP

  • Financing Rounds
  • 6

  • Investments
  • 1

CorePharma General Information

Description

Developer and manufacturer of solid dose generic pharmaceuticals, including prescription and over-the-counter products. The company's focuses on solid oral dosage forms, both modified and immediate release dosage forms and controlled drug products under various brands, enabling patients to get over chronic diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Corporate Office
  • 215 Wood Avenue
  • Middlesex, NJ 08846
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CorePharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CorePharma‘s full profile, request access.

Request a free trial

CorePharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and manufacturer of solid dose generic pharmaceuticals, including prescription and over-the-counter products.
Pharmaceuticals
Middlesex, NJ
000000000 -

0000 0

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
000000000000000
Monmouth Junction, NJ
000 As of 0000
000000000 -

00000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
000000000000000
Manalapan Township, NJ
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CorePharma Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tris Pharma Private Debt Financed Monmouth Junction, NJ 000 000000000 -
Armas Pharmaceuticals Corporation Manalapan Township, NJ 00
Teva Pharmaceutical Industries Corporate Backed or Acquired Petah Tikva, Israel 00000 000.00 000000000 00 000.00
You’re viewing 3 of 3 competitors. Get the full list »

CorePharma Executive Team (13)

Name Title Board Seat Contact Info
Arpit Patel Chief Executive Officer & Board Member
Vithal Dhaduk MD Co-Founder, President & Chairman
You’re viewing 2 of 13 executive team members. Get the full list »

CorePharma Board Members (4)

Name Representing Role Since
00000 00000 CorePharma Chief Executive Officer & Board Member 000 0000
000000 000000 00 CorePharma Co-Founder, President & Chairman 000 0000
You’re viewing 2 of 4 board members. Get the full list »

CorePharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CorePharma‘s full profile, request access.

Request a free trial

CorePharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Leucovorin Calcium Tablets 16-Mar-2009 0000000000 Pharmaceuticals 000000000
To view CorePharma’s complete investments history, request access »

CorePharma FAQs

  • When was CorePharma founded?

    CorePharma was founded in 1998.

  • Who is the founder of CorePharma?

    Vithal Dhaduk MD is the founder of CorePharma.

  • Who is the CEO of CorePharma?

    Arpit Patel is the CEO of CorePharma.

  • Where is CorePharma headquartered?

    CorePharma is headquartered in Middlesex, NJ.

  • What industry is CorePharma in?

    CorePharma’s primary industry is Pharmaceuticals.

  • Is CorePharma a private or public company?

    CorePharma is a Private company.

  • What is CorePharma’s current revenue?

    The current revenue for CorePharma is 000000.

  • Who are CorePharma’s investors?

    Impax Laboratories, PNC Erieview Capital, and RoundTable Healthcare Partners have invested in CorePharma.

  • Who are CorePharma’s competitors?

    Tris Pharma, Armas Pharmaceuticals, and Teva Pharmaceutical Industries are competitors of CorePharma.

  • When was CorePharma acquired?

    CorePharma was acquired on 16-Apr-2020.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »